{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:43:17Z","timestamp":1793752997259,"version":"4.6.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.dsx.2021.102294","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T17:12:29Z","timestamp":1632157949000},"page":"102294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Continuous glucose monitoring and Rituximab treatment in insulin autoimmune syndrome"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7868-8026","authenticated-orcid":false,"given":"Hiya","family":"Boro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttio","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhi","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Khadgawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2021.102294_bib1","first-page":"312","article-title":"Insulin autoimmunity in a case of spontaneous hypoglycaemia","volume":"13","author":"Hirata","year":"1970","journal-title":"J\u00a0Jpn Diabetes Soc"},{"key":"10.1016\/j.dsx.2021.102294_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0168-8227(90)90063-Y","article-title":"Insulin autoimmune syndrome is the third leading cause of spontaneous hypoglycemic attacks in Japan","volume":"10","author":"Takayama-Hasumi","year":"1990","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2021.102294_bib3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1515\/cclm-2017-0392","article-title":"Insulin autoimmune syndrome (Hirata's disease) in an Italian patient: a case report and review of the literature","volume":"56","author":"Censi","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.dsx.2021.102294_bib4","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2018.07.32","article-title":"Insulin autoimmune syndrome: from diagnosis to clinical management","volume":"6","author":"Censi","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.dsx.2021.102294_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.mayocp.2012.09.006","article-title":"69-Year-Old man with: recurrent episodes of confusion and diaphoresis","volume":"88","author":"Donegan","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.dsx.2021.102294_bib6","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1210\/jc.2016-1097","article-title":"Novel management of insulin autoimmune syndrome with Rituximab and continuous glucose monitoring","volume":"101","author":"Saxon","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2021.102294_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2337\/dc17-0264","article-title":"Resolution of hypoglycemia and cardiovascular dysfunction after Rituximab treatment of insulin autoimmune syndrome","volume":"40","author":"Church","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2021.102294_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2337\/dc17-1974","article-title":"Immunoadsorption followed by Rituximab as a definitive treatment for insulin autoimmune syndrome (Hirata syndrome): a case report","volume":"41","author":"Kroemer","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2021.102294_bib9","article-title":"Rituximab for treatment of refractory insulin autoimmune syndrome associated with non-Hodgkin B-cell lymphoma","volume":"14","author":"Chen","year":"2019","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.dsx.2021.102294_bib10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2169\/internalmedicine.46.0221","article-title":"The novel agent, alpha lipoic acid, can cause the development of insulin autoimmune syndrome","volume":"46","author":"Uchigata","year":"2007","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.dsx.2021.102294_bib11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11606-013-2588-9","article-title":"Recurrent hypoglycemia from insulin autoimmune syndrome","volume":"29","author":"Wong","year":"2014","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.dsx.2021.102294_bib12","first-page":"237","article-title":"The surgical therapy of hyperinsulinism","volume":"3","author":"Whipple","year":"1938","journal-title":"J\u00a0Int Chir"},{"issue":"8790","key":"10.1016\/j.dsx.2021.102294_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0140-6736(92)90080-M","article-title":"Strong association of insulin autoimmune syndrome with HLA-DR4","volume":"339","author":"Uchigata","year":"1992","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.dsx.2021.102294_bib14","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1111\/dme.12418","article-title":"Use of the continuous glucose monitoring system to treat insulin autoimmune syndrome: quantification of glucose excursions and evaluation of treatment efficacy","volume":"31","author":"Philippon","year":"2014","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.dsx.2021.102294_bib15","first-page":"e260","article-title":"Long-term prevention of hypoglycemia by conservatively managed insulin autoimmune syndrome","volume":"2","author":"Peters","year":"2016","journal-title":"AACE Clin Case Rep"},{"issue":"5","key":"10.1016\/j.dsx.2021.102294_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0300-2977(95)00085-2","article-title":"Recurrent hypoglycaemia caused by the insulin autoimmune syndrome: the first Dutch case","volume":"48","author":"Schlemper","year":"1996","journal-title":"Neth J Med"},{"issue":"5","key":"10.1016\/j.dsx.2021.102294_bib17","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.3892\/etm.2016.3767","article-title":"Insulin-induced autoimmune syndrome: a case report","volume":"12","author":"Chu","year":"2016","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1016\/j.dsx.2021.102294_bib18","first-page":"59","article-title":"Insulin autoimmune syndrome revealing systemic lupus erythematosus","volume":"154","author":"Rouabhia","year":"2003","journal-title":"Ann Med Interne"},{"issue":"1","key":"10.1016\/j.dsx.2021.102294_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1464-5491.2008.02621.x","article-title":"Severe insulin resistance due to anti-insulin antibodies: response to plasma exchange and immunosuppressive therapy","volume":"26","author":"Greenfield","year":"2009","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.dsx.2021.102294_bib20","doi-asserted-by":"crossref","DOI":"10.4093\/dmj.2015.39.2.126","article-title":"Clinical features and causes of endogenous hyperinsulinemic hypoglycemia in Korea","volume":"39","author":"Woo","year":"2015","journal-title":"Diabetes Metab J"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121003143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121003143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:17:08Z","timestamp":1761729428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402121003143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1871402121003143"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2021.102294","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous glucose monitoring and Rituximab treatment in insulin autoimmune syndrome","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2021.102294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102294"}}